Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Trimesta (Oral Estriol)
A silver lining of neuroinflammation: Beneficial effects on myelination.
Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials.
Dimethyl fumarate inhibits the expression and function of hypoxia-inducible factor-1α (HIF-1α).
Leisure time activities of Iranian patients with multiple sclerosis: a qualitative study.
Multiple Sclerosis: Modulation of Toll-Like Receptor (TLR) Expression by Interferon-β Includes Upregulation of TLR7 in Plasmacytoid Dendritic Cells.
Demyelination induces transport of ribosome-containing vesicles from glia to axons: evidence from animal models and MS patient brains.
The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis.
Assessment of structural and functıonal vısual outcomes ın relapsıng remıttıng multıple sclerosıs wıth vısual evoked potentıals and optıcal coherence tomography.
A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.
A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients.
Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.
Teriflunomide in multiple sclerosis: Added benefit not proven
A case of posterior reversible encephalopathy syndrome associated with gilenya(®) (fingolimod) treatment for multiple sclerosis.
More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.
Laquinimod in Relapsing-Remitting Multiple Sclerosis
Patient trial of immunization to treat Alzheimer’s disease begins at Cedars-Sinai
Morphogenesis of the demyelinating lesions in Baló's concentric sclerosis.
Zebrafish as a model to investigate CNS myelination.
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study.
Switch to natalizumab vs fingolimod in active relapsing-remitting multiple sclerosis.
Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literature.
Altered intra- and interregional synchronization in relapsing-remitting multiple sclerosis: a resting-state fMRI study.
Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity.

Pages